PREDNISOLONE SODIUM PHOSPHATE | A076913 | PHARMACEUTICAL ASSOC INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Lowenstein Sandler on behalf of PAI Holdings, LLC dba P... FDA-2026-P-7013 · 2 docket documents Lowenstein Sandler, on behalf of PAI Holdings LLC (doing business as Pharmaceutical Associates, Inc. and PAI Pharma), filed a citizen petition requesting that the FDA take unspecified regulatory action regarding pharmaceutical products under the petitioner's purview, though the specific drug names, | Other | 2026-06-24 | Open | PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.1047
per ml
Lowest NADAC/Unit
$0.1047
per ml
Brand NDCs
0
Generic NDCs
1
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00121075908PREDNISOLONE 15 MG/5 ML SOLN | $0.1047 | ML | Generic | — | 2026-08-19 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.